Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

MoonLake Immunotherapeutics

NASDAQ: MLTX · Life Sciences · 2 alerts · CIK 1821586

Share price
$11.73Close, Nov 16
Market cap
$998M
Shares outstanding
85.11MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All MoonLake Immunotherapeutics filings on SEC EDGAR ↗

7:07 AM ET 8-K
Financial Results

MoonLake Immunotherapeutics Financial Results

MoonLake Immunotherapeutics reported Q3 2026 financial results and announced the submission of a Biologics License Application (BLA) to the FDA for sonelokimab in hidradenitis suppurativa. The company ended the quarter with $498.5 million in cash and equivalents, providing a projected cash runway into mid-2028.

Term
Q3 2026
4:15 PM ET 8-K
Business Update

MoonLake Immunotherapeutics Business Update

MoonLake Immunotherapeutics has submitted a Biologics License Application (BLA) to the FDA for its tri-specific nanobody sonelokimab. The application seeks approval for the treatment of moderate-to-severe hidradenitis suppurativa in adults and pediatric patients. The company expects notification regarding the acceptance of the BLA for review within approximately 60 days.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.